Snapshots from the Edge | David Pardoe on AI’s Role in Revolutionizing Drug Discovery

“Now is the time that we DO need automation … to harvest all of that information and data – largely unstructured – to put it into a form that we can easily exploit and explore, and to help us make those really difficult decisions in drug discovery and development.”

David Pardoe, SVP and Head of Global Molecular Architects at Evotec, lays out the stark challenges for drug discovery, and the urgent response that AI can help to drive.